PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Apr-2023 Endodontics and Orthodontics Market is expected to expand at a 5.3% CAGR through 2032 | FMI MARKITWIRED
06-Apr-2023 Alpha Cancer Technologies (ACT) Publishes Pre-Clinical Study Results in Cancer Cell International Demonstrating Excellent Safety and Significant Anti-Tumor Activity from the Company’s Next Generation ADC, ACT-903 Businesswire
06-Apr-2023 Mauna Kea Technologies publie ses résultats annuels 2022 Businesswire
06-Apr-2023 TP ICAP Midcap Initiates Coverage of Pherecydes Pharma With a “Buy” Recommendation Businesswire
06-Apr-2023 Mauna Kea Technologies Reports 2022 Annual Results Businesswire
06-Apr-2023 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill Vita 34 AG
06-Apr-2023 RQM+ Appoints Denise Wocko as Head of Global Client Portfolio Management Businesswire
06-Apr-2023 SubjectWell Expands Executive Leadership to Realize Growth Strategy Businesswire
06-Apr-2023 Boston BioProducts Receives ISO 13485:2016 Quality Certification Businesswire
06-Apr-2023 restor3d Receives FDA Clearance of Patient Specific Resection Guides for use with the Kinos Axiom Total Ankle System Businesswire
06-Apr-2023 VanEck Launches Robotics ETF (IBOT) Businesswire
06-Apr-2023 Industry Leader Tim Walbert Joins Mirum Pharmaceuticals’ Board of Directors Businesswire
06-Apr-2023 Ora, Inc. Appoints Paul Colvin as Chief Operating Officer Businesswire
06-Apr-2023 Vistagen Receives New European Patent for AV-101 Businesswire
06-Apr-2023 Affini-T Therapeutics to Present Preclinical Data from its Oncogenic Driver Program Targeting KRAS at the American Association for Cancer Research (AACR) Annual Meeting 2023 Businesswire
06-Apr-2023 PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery Businesswire
06-Apr-2023 Thermo Fisher Scientific Expansion in France Boosts Capabilities from Development to Commercial Manufacturing Businesswire
06-Apr-2023 Peptilogics Completes Phase 1b Trial Enrollment and Will Present Interim Top-line Safety and Tolerability Data of PLG0206 in Patients Undergoing DAIR for the Treatment of Periprosthetic Joint Infection After a Total Knee Arthroplasty at ECCMID 2023 Businesswire
06-Apr-2023 Rallybio Announces Clinical Proof-of-Concept Results for RLYB211, an Anti-HPA-1a Polyclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), Published in the Journal of Thrombosis and Haemostasis Businesswire
06-Apr-2023 Henry Schein Completes Strategic Partnership With Biotech Dental Group Businesswire